Cell Therapy

Can Congress Improve Veterans’ Access to Non-VA Care?
Research & Development Can Congress Improve Veterans’ Access to Non-VA Care?

Picture a veteran, a Marine Corps and Army hero like John-Paul Sager, sitting in a small-town clinic just miles from home, yet unable to get treatment for chronic pain without wading through a swamp of paperwork and approvals. Across the nation, thousands of veterans face this reality, driving past

Can U.S. Organ Transplant Reforms Restore Public Trust?
Research & Development Can U.S. Organ Transplant Reforms Restore Public Trust?

In a nation where thousands of lives hang in the balance awaiting organ transplants, the U.S. system has long been plagued by systemic failures that have eroded public confidence. Reports of operational flaws, lack of accountability, and even shocking practices—such as initiating organ donation

Immunotherapy Breakthrough Shows Promise for AML Treatment
Research & Development Immunotherapy Breakthrough Shows Promise for AML Treatment

Is the future of cancer therapy already taking shape in laboratories today? With each advance in medical science, there comes hope for more effective treatments against malignant diseases. Immunotherapy, a rapidly evolving approach, has been positioned as a groundbreaking method in combating cancer

Can Targeting Senescent Macrophages Transform Cancer Therapy?
Research & Development Can Targeting Senescent Macrophages Transform Cancer Therapy?

As researchers intensify their quest to understand cancer progression, the spotlight has unexpectedly turned toward a surprising villain: senescent macrophages. These paradoxical cells, originally hailed as immune defenders, are now under scrutiny for their complicity in fueling tumor growth. The

Galapagos Shifts Strategy, Considers Selling Cell Therapy Unit
Research & Development Galapagos Shifts Strategy, Considers Selling Cell Therapy Unit

In a bold maneuver to realign its strategic focus, Belgian pharmaceutical firm Galapagos is contemplating the sale of its cell therapy unit, a move that represents a significant departure from its initial restructuring plan. Originally, this unit was poised to become the cornerstone of a strategic

Strong ADCC Activity vs. Minimal ADCC Activity: A Comparative Analysis
Research & Development Strong ADCC Activity vs. Minimal ADCC Activity: A Comparative Analysis

In the ever-evolving landscape of cancer therapies, one of the most significant breakthroughs has been the use of monoclonal antibodies and immune checkpoint inhibitors (ICIs). These therapies aim to enhance the immune system's ability to recognize and eliminate tumors. However, the effectiveness

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later